IRWD icon

Ironwood Pharmaceuticals

227 hedge funds and large institutions have $1.12B invested in Ironwood Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 80 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

26% less capital invested

Capital invested by funds: $1.5B → $1.12B (-$383M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

59% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 51

Holders
227
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$73.6M
Puts
$186K
Net Calls
Net Calls Change

Top Buyers

1 +$15.6M
2 +$14.2M
3 +$13.3M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
+$11.1M
5
Renaissance Technologies
Renaissance Technologies
New York
+$9.6M

Top Sellers

1 -$30.5M
2 -$9.02M
3 -$8.35M
4
UBS Group
UBS Group
Switzerland
-$7.75M
5
SSA
Schonfeld Strategic Advisors
New York
-$6.29M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$526K
102
$525K
103
$523K
104
$503K
105
$502K
106
$491K
107
$474K
108
$470K
109
$459K
110
$445K
111
$440K
112
$433K
113
$432K
114
$415K
115
$407K
116
$400K
117
$394K
118
$392K
119
$392K
120
$391K
121
$376K
122
$364K
123
$359K
124
$356K
125
$329K